Tanvex BioPharma (Taiwan) Market Value

6541 Stock  TWD 72.30  6.20  9.38%   
Tanvex BioPharma's market value is the price at which a share of Tanvex BioPharma trades on a public exchange. It measures the collective expectations of Tanvex BioPharma investors about its performance. Tanvex BioPharma is selling for under 72.30 as of the 2nd of December 2024; that is 9.38 percent increase since the beginning of the trading day. The stock's lowest day price was 66.4.
With this module, you can estimate the performance of a buy and hold strategy of Tanvex BioPharma and determine expected loss or profit from investing in Tanvex BioPharma over a given investment horizon. Check out Tanvex BioPharma Correlation, Tanvex BioPharma Volatility and Tanvex BioPharma Alpha and Beta module to complement your research on Tanvex BioPharma.
Symbol

Please note, there is a significant difference between Tanvex BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tanvex BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tanvex BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tanvex BioPharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tanvex BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tanvex BioPharma.
0.00
12/13/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
12/02/2024
0.00
If you would invest  0.00  in Tanvex BioPharma on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Tanvex BioPharma or generate 0.0% return on investment in Tanvex BioPharma over 720 days. Tanvex BioPharma is related to or competes with Adimmune Corp, Panion BF, OBI Pharma, Lotus Pharmaceutical, and TaiMed Biologics. Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of bios... More

Tanvex BioPharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tanvex BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tanvex BioPharma upside and downside potential and time the market with a certain degree of confidence.

Tanvex BioPharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Tanvex BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tanvex BioPharma's standard deviation. In reality, there are many statistical measures that can use Tanvex BioPharma historical prices to predict the future Tanvex BioPharma's volatility.
Hype
Prediction
LowEstimatedHigh
69.7872.3074.82
Details
Intrinsic
Valuation
LowRealHigh
67.0369.5579.53
Details
Naive
Forecast
LowNextHigh
70.6273.1475.65
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
59.1465.4171.68
Details

Tanvex BioPharma Backtested Returns

At this stage we consider Tanvex Stock to be very steady. Tanvex BioPharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0017, which indicates the firm had a 0.0017% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Tanvex BioPharma, which you can use to evaluate the volatility of the company. Please validate Tanvex BioPharma's Semi Deviation of 1.77, coefficient of variation of 1843.06, and Risk Adjusted Performance of 0.0487 to confirm if the risk estimate we provide is consistent with the expected return of 0.0042%. The entity has a beta of 0.51, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tanvex BioPharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tanvex BioPharma is expected to be smaller as well. Tanvex BioPharma right now has a risk of 2.52%. Please validate Tanvex BioPharma downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Tanvex BioPharma will be following its existing price patterns.

Auto-correlation

    
  -0.46  

Modest reverse predictability

Tanvex BioPharma has modest reverse predictability. Overlapping area represents the amount of predictability between Tanvex BioPharma time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tanvex BioPharma price movement. The serial correlation of -0.46 indicates that about 46.0% of current Tanvex BioPharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.46
Spearman Rank Test-0.07
Residual Average0.0
Price Variance108.76

Tanvex BioPharma lagged returns against current returns

Autocorrelation, which is Tanvex BioPharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tanvex BioPharma's stock expected returns. We can calculate the autocorrelation of Tanvex BioPharma returns to help us make a trade decision. For example, suppose you find that Tanvex BioPharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Tanvex BioPharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tanvex BioPharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tanvex BioPharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tanvex BioPharma stock over time.
   Current vs Lagged Prices   
       Timeline  

Tanvex BioPharma Lagged Returns

When evaluating Tanvex BioPharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tanvex BioPharma stock have on its future price. Tanvex BioPharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tanvex BioPharma autocorrelation shows the relationship between Tanvex BioPharma stock current value and its past values and can show if there is a momentum factor associated with investing in Tanvex BioPharma.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tanvex Stock Analysis

When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.